Preclinical Pharmacokinetics of a Triple-Combination Intravaginal Ring for HIV Prevention
John A. Moss, Marc M. Baum(Oak Crest Institute of Science), Christina M. Ramirez(University of California, Los Angeles), Kristen Kelley(Columbia College - South Carolina), Irina Butkyavichene(Oak Crest Institute of Science), Dawn Little(Anchorage School District), John Cortez(Oak Crest Institute of Science), Chuong Dinh(National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention), Sofía Rivera(Oak Crest Institute of Science), Jining Zhang(National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention), Amalia E. Castonguay(Oak Crest Institute of Science), Patricia Galván(Vall d'Hebron Institute of Oncology), Philippe Gallay(Scripps Research Institute), Manjula Gunawardana(Oak Crest Institute of Science), Priya Srinivasan(National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention), Kathleen L. Vincent(The University of Texas Medical Branch at Galveston), James M. Smith(National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention), Angela Holder(National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention), Shanon Bachman(Decatur Memorial Hospital)
Cited by 0
Related Papers
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
|Science|1996|4.9k
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
|Blood|2004|787
HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
|Proceedings of the National Academy of Sciences|1997|483